Fenoldopam mesylate and renal function in patients undergoing liver transplantation: A randomized, controlled pilot trial

Anesthesia and Analgesia

Volumn 99, Issue 6, 2004, Pages 1604-1609

  Della Rocca, G ^a,c   Pompei, L ^a   Costa, M G ^a   Coccia, C ^a   Scudeller, L ^a   Di Marco, P ^b   Monaco, S ^b   Pietropaoli, P ^b  

^a UNIVERSITY OF UDINE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; FENOLDOPAM MESILATE; FUROSEMIDE; MANNITOL;

ADULT; AGED; ANESTHESIA INDUCTION; ARTICLE; BLOOD VOLUME; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; FEMALE; HEMODYNAMICS; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; LIVER TRANSPLANTATION; LUNG FLUID; MALE; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UREA NITROGEN BLOOD LEVEL; URINE VOLUME;

EID: 9244253239     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000136420.01393.81     Document Type: Article

References (28)

1. Fraley DS, Burr R, Bernardini J, et al. Impact of acute renal failure on mortality in end-stage liver disease with or without transplantation. Kidney Int 1998;54:518-24.
2. Bilbao I, Charco L, Balsells J, et al. Risk factors for acute renal failure requiring dialysis after liver transplantation. Clin Transplant 1998;12:123-9.
3. Bellomo R, Kellum J, Ronco C. Acute renal failure: time for consensus. Intensive Care Med 2001;27:1685-8.
4. Mathur V, Swan SK, Lambrecht LJ, et al. The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects. Crit Care Med 1999;27:1832-7.
5. Mathur VS, O'Connell DO, Carey RG. Renal hemodynamic effects of very low dose fenoldopam. Anesth Analg 1999;88:SCA 85.
6. Kohli JD, Glock D, Goldberg LI. Relative DA1-dopamine-receptor agonist and α-adrenoreceptor antagonist activity of fenoldopam in the anesthetized dog. J Cardiovasc Pharmacol 1988;11:123-6.
7. Oparil S, Aronson S, Deeb GM, et al. Fenoldopam: a new parenteral antihypertensive - consensus roundtable on the management of perioperative hypertension and hypertensive crises. Am J Hypertens 1999;12:653-64.
8. Garwood S, Hines R. Perioperative renal preservation: dopexamine and fenoldopam - new agents to augment renal performance. Semin Anesth Periop Med Pain 1998;17:308-18.
9. Allison NL, Dubb JW, Ziemniak JA, et al. The effect of fenoldopam, a dopaminergic agonist, on renal hemodynamics. Clin Pharmacol Ther 1987;41:282-8.
10. Tumlin JA, Dunbar LM, Oparil S. Fenoldopam, a dopamine agonist, for hypertensive emergency: a multicenter randomized trial. Acad Emerg Med 2000;7:653-62.
11. Mathur VS. The role of the DA1 receptor agonist fenoldopam in the management of critically ill, transplant and hypertensive patients. Rev Cardiovasc Med 2003;4(Suppl 1):S35-40.
12. Halpenny M, Lakshmi S, O'Donnell A, et al. Fenoldopam: renal and splanchnic effects in patients undergoing coronary artery bypass grafting. Anaesthesia 2001;56:953-60.
13. Halpenny M, Rushe C, Breen P, et al. The effects of fenoldopam on renal function in patients undergoing elective aortic surgery. Eur J Anaesthesiol 2002;19:32-9.
14. Ramsay MA, Jones CC, Emmett ME. The effect of a fenoldopam infusion on postoperative renal function in patients undergoing liver transplantation. Anesthesiology 2002;A242.
15. Star RA. Treatment of acute renal failure. Kidney Int 1998;54:1817-31.
16. Dishart MK, Kellum JA. An evaluation of pharmacological strategies for the prevention and treatment of acute renal failure. Drugs 2000;59:79-91.
17. MacGregor DA, Prielipp RC, Black CS, et al. Renal dose dopamine does not alter the response to β-adrenergic stimulation by isoproterenol in healthy human volunteers. Chest 1997;112:40-4.
18. MacGregor DA, Smith TE, Prielipp RC, et al. Pharmacokinetics of dopamine in healthy male subjects. Anesthesiology 2000;92:338-46.
19. Jorkasky DK, Audet P, Shusterman N, et al. Fenoldopam reverses cyclosporine-induced renal vasoconstriction in kidney transplant recipients. Am J Kidney Dis 1992;19:567-72.
20. Sirivella S, Gielchinsky I, Parsonnet V, et al. Mannitol, furosemide and dopamine infusion in postoperative renal failure complicating cardiac surgery. Ann Thorac Surg 2000;69:501-6.
21. Lassnigg A, Donner E, Grubhofer G, et al. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol 2000;11:97-104.
22. Polson RJ, Park GR, Lindop MJ, et al. The prevention of renal impairment in patients undergoing orthotopic liver grafting by infusion of low dose dopamine. Anesthesia 1987;42:15-9.
23. Swygert TH, Roberts LC, Valek TL, et al. Effect of intraoperative low dose dopamine on renal function in liver transplant recipients. Anesthesiology 1991;75:571-6.
24. Myles PS, Buckland MR, Schenk NJ, et al. Effects of "renal- dose" dopamine on renal function following cardiac surgery. Anaesth Intensive Care 1993;21:56-61.
25. Carey RM, Siragy HM, Ragsdale NV, et al. Dopamine-1 and dopamine-2 mechanism in control of renal function. Am J Hypertens 1990;56:59s-63s.
26. Bailey JM. Dopamine: one size does not fit all. Anesthesiology 2000;92:303-5.
27. Marik PE. Low-dose dopamine: a systematic review. Intensive Care Med 2002;28:877-83.
28. Holmes CL, Walley KR. Bad medicine: low-dose dopamine in the ICU. Chest 2003;123:1266-75.